M Hatae

Phase II Study of Irinotecan and Cisplatin as First-Line Chemotherapy in Advanced or Recurrent Cervical Cancer

Toru Sugiyama, M Yakushiji, Kiichiro Noda et al. · Oncology · 2000 · 81 citations

Medicine, Oncology, Surgery +17

Phase II Clinical Trial of Pegylated Liposomal Doxorubicin (JNS002) in Japanese Patients with Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having a Therapeutic History of Platinum-based Chemotherapy: A Phase II Study of the Japanese Gynecologic Oncology Group

Noriyuki Katsumata, Yasuhiro Fujiwara, Toshiharu Kamura et al. · Japanese Journal of Clinical Oncology · 2008 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase III placebo-controlled double-blind randomized trial of radiotherapy for stage IIB–IVA cervical cancer with or without immunomodulator Z-100: a JGOG study

Toru Sugiyama, Keiichi Fujiwara, Yasuo Ohashi et al. · Annals of Oncology · 2014 · 30 citations · Full text

Medicine, Oncology, Radiation Oncology +8

Comparison of adjuvant chemotherapy and radiotherapy in patients with cervical adenocarcinoma of the uterus after radical hysterectomy: SGSG/TGCU Intergroup surveillance.

Muneaki Shimada, R Nishimura, M Hatae et al. · PubMed · 2013 · 20 citations

Medicine, Oncology, Surgery +17